Thyroid Cancer: What Are the Latest Advances in Treatment?

Thyroid cancer is usually a highly treatable malignancy with overall five-year survival rates over 98%. Many patients with thyroid cancer go on to live for several decades after their disease is cured.

By
September 29, 2026
6 min

Keck Medicine of USC

1

Thyroid cancer has a five-year survival rate exceeding 98%, with many patients living decades after treatment.
2

Molecular testing is now standard in thyroid cancer care, helping to classify nodules and guide treatment decisions.
3

Updated American Thyroid Association guidelines have reclassified oncocytic thyroid cancer and introduced four risk categories.
4

Surgical options have shifted towards lobectomy for low-risk tumors, reducing long-term dependency on hormone replacement.
5

Active surveillance is recommended for some patients with small, slow-growing tumors, especially those at high surgical risk.

Thyroid Cancer: What Are the Latest Advances in Treatment?

1

2

3

4

5

Original Source(s)

Thyroid Cancer: What Are the Latest Advances in Treatment?

Related Content

Overall Survival Benefit and Long-Term Safety of Romiplostim in Persistent Chemotherapy-Induced Thrombocytopenia

Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology

Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia